Intellia Therapeutics, Inc.

NTLA · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances · Market Cap: $1.6B · 377 employees
208
SEC Filings
$9.7
Close 2026-11-13
377
Employees

Business Summary

Intellia Therapeutics is a biopharmaceutical company focused on CRISPR-based gene editing therapies. Its lead product candidates are lonvoguran ziclumeran (lonvo-z, NTLA-2002) for hereditary angioedema and nexiguran ziclumeran (nex-z, NTLA-2001) for transthyretin amyloidosis, both in Phase 3 development. The company leverages proprietary CRISPR, lipid nanoparticle (LNP), and oligonucleotide technologies to develop in vivo genome editing treatments administered as a single IV infusion, with a planned commercial launch of lonvo-z in the first half of 2027.

Latest Stock Quote

NTLA 2026-11-13 $9.7 O:$10.45 H:$10.505 L:$9.665 Vol:11.4M VWAP:$9.9428
origin leaf: null

Next Earnings

expected 2027-02-04

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-076550EDGAR95K words
2025-02-272024-12-310000950170-25-029007EDGAR95K words
2024-02-222023-12-310000950170-24-018736EDGAR99K words
2023-02-232022-12-310000950170-23-004097EDGAR101K words
2022-02-242021-12-310000950170-22-001981EDGAR103K words
2021-02-262020-12-310001564590-21-009011EDGAR93K words
2020-02-272019-12-310001564590-20-007409EDGAR102K words
2019-02-272018-12-310001564590-19-004680EDGAR93K words
2018-03-142017-12-310001564590-18-005544EDGAR83K words
2017-03-142016-12-310001193125-17-082186EDGAR78K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-052026-09-300001193125-26-449862EDGAR61K words
2026-08-062026-06-300001193125-26-337952EDGAR59K words
2025-11-062025-09-300001193125-25-269680EDGAR62K words
2025-08-072025-06-300000950170-25-104987EDGAR60K words
2025-05-082025-03-310000950170-25-066914EDGAR56K words
2024-11-072024-09-300000950170-24-123276EDGAR58K words
2024-08-082024-06-300000950170-24-093907EDGAR57K words
2024-05-092024-03-310000950170-24-057046EDGAR54K words
2023-11-092023-09-300000950170-23-062011EDGAR61K words
2023-08-032023-06-300000950170-23-037996EDGAR60K words
2023-05-042023-03-310000950170-23-017866EDGAR56K words
2022-11-032022-09-300000950170-22-021835EDGAR67K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-120001193125-26-458422EDGAR7K words
2026-11-050001193125-26-448673EDGAR3K words
2026-09-080001193125-26-385194EDGAR1K words
2026-09-040001193125-26-383645EDGAR1K words
2026-08-060001193125-26-336772EDGAR3K words
2026-03-020001193125-26-084309EDGAR2K words
2026-02-260001193125-26-073456EDGAR3K words
2026-01-270001193125-26-023387EDGAR1K words
2026-01-090001193125-26-008307EDGAR6K words
2025-11-100001193125-25-274596EDGAR2K words

208 total filings indexed. 176 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. TKNO — Alpha Teknova, Inc. NNNN — Anbio Biotechnology AWHL — Aspira Women's Health Inc. BMRA — BIOMERICA INC BZYR — BURZYNSKI RESEARCH INSTITUTE INC CDIO — Cardio Diagnostics Holdings, Inc. CLDX — Celldex Therapeutics, Inc.

Tags

hereditary-angioedema-(hae) transthyretin-amyloidosis-(attr) rare-genetic-diseases gene-editing-therapeutics crispr-based-gene-editing lipid-nanoparticles-(lnp) oligonucleotide-technology in-vivo-genome-editing

Company Identity

CIK0001652130
TickerNTLA
ExchangeNasdaq
SIC2835: In Vitro & In Vivo Diagnostic Substances
IncorporatedDE
Websitehttps://www.intelliatx.com
Listed2016-05-06

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: ff9d4956ed47c2702e2650ea2689d8ce47d4065963a570cc78abba049d742fef
parent: 6684c258326069532d9b9a1dec263a629b371208f33052255d0ccbf2249b5dc9
content hash: 8a2f352735890c3e0e0e9ae5a57b6923d025d27fab7333c61efc8f60e0b60b29
signed: 2026-11-16T19:03:51.838Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up NTLA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on NTLA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/NTLA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.